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Spans 365 kb; 5 exons. 
Transcription 
A major transcript of 7.5 kb. 
Protein 
Description 
1153 aa, 125 kDa; conserved N-terminal basic domain 
(aa 29-92) which binds to the ankyrin repeat domain of 
Notch receptors; two acidic domains (aa 263-360 and 







Mastermind-like coactivator for all four Notch 
receptors; forms a complex with the Notch intracellular 
domain (Notch ICD) and the CSL family of 
transcription factors (CSL: CBF1/RBP-jk, Suppressor 
of Hairless, LAG1), resulting in activation of the Notch  
target genes HES1 and HES5; functions as a CSL-
dependent transcriptional coactivator for ligand-
stimulated Notch. 
Homology 
MAML1 and MAML3. 
Implicated in 
Mucoepidermoid carcinoma with 
t(11;19)(q21-22;p13) 
Disease 
- Most common type of malignant salivary gland 
tumor; 
- Second most frequent lung tumor of bronchial gland 
origin;  
- Rare tumour in the thyroid. 
The t(11;19) was found in samples from the three 
different sites. 
Prognosis 
- Mucoepidermoid carcinomas have an unpredictable 
behaviour. 
- The CRTC1-MAML2 fusion transcript was found 
equally in low, intermediate and high grade tumours; 
however, tumours lacking the fusion transcript were 
significantly associated with metastases; they may 
represent a subset of aggressive tumours. 
- In another study, the median survival for fusion-
positive patients was greater than 10 years compared to 
1.6 years for fusion-negative patients. 
Hybrid/Mutated Gene 
CRTC1-MAML2; exon 1 of CRTC1 fused to exons 2-5 
of MAML2. Note: CRTC1 is also known as MECT1, 
or WAMTP1. 










CRTC1-MAML2. In the fusion protein, the first 171 aa
including the basic domain of MAML2 are replaced by 
42 aa of CRTC1; there are no sequence similarities in 
the N-terminal domains of MAML2 and CRTC1. The 
fusion protein activates transcription of the Notch 
target gene HES1 independently of both Notch ligand 
and CSL. 
Transforming activity of CRTC1-MAML2 fusion 
oncoprotein is mediated by mimicking constitutive 
activation of cAMP signaling, by activating CREB 
directly. 
Warthin's tumor with t(11;19)(q21-
22;p13) 
Note: In rare instances mucoepidermoid carcinoma 
may arise from or coexist with Warthin's tumors. 
Disease 
Warthin's tumor is a salivary gland neoplasm consisti g 
of benign epithelial and lymphoid components; 
malignant transformation is extremely rare. 
Hybrid/Mutated Gene 
CRTC1-MAML2 
Clear cell hidradenomas of the skin with 
t(11;19)(q21-22;p13) 
Disease 
Clear cell hidradenomas of the skin are benign sweat 
gland tumors of eccrine duct origin. 
Hybrid/Mutated Gene 
CRTC1-MAML2; exon 1 of CRTC1 fused to exons 2 
of MAML2. 
inv(11)(q21q23) in therapy related 
leukemias 
Disease 
Therapy-related acute leukemia and MDS. 
 
Hybrid/Mutated Gene 
MLL-MAML2; exon 1-7 of MLL fused to exons 2-5 of 
MAML2. 
Abnormal Protein 
Hybrid transcript MLL/MAML2 contains the following 
domains: from MLL: AT-hook, DNA-
Methyltransferase; from MAML2: Q rich domain, 
acidic domain. 
To be noted 
Note: It is amazing that a similar fusion transcript 
(CRTC1-MAML2) can be seen both in a benign and in 
a malignant tumour of the same organ: Warthin's 
tumor, a benign salivary gland neoplasm, and 
mucoepidermoid carcinoma of the salivary gland: 
either another event differentiate the two, or the genetic 
event takes place in different cell types or in a given 
cell type at different states of differenciation. 
It has been hypothezised that CRTC1-MAML2 fusion 
is etiologically linked to benign and low-grade 
malignant tumors originating from diverse exocrine 
glands rather than being linked to a separate tumor 
entity. 
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